Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs Healthcare C-Suite Unscripted Conference
28 Décembre 2023 - 1:00PM
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced
that the company will host a fireside chat at the Goldman Sachs
Healthcare C-Suite Unscripted Conference on Thursday, January 4,
2023, at 2:25 p.m. ET.
The event will be available via a live webcast
from the “Events and Presentations” page of the “Investors and
Media” section of the company’s website. A replay of the webcast
will be available for approximately 90 days following the
event.
About ApellisApellis
Pharmaceuticals, Inc. is a global biopharmaceutical company that
combines courageous science and compassion to develop life-changing
therapies for some of the most challenging diseases patients face.
We ushered in the first new class of complement medicine in 15
years and now have two approved medicines targeting C3. These
include the first and only therapy for geographic atrophy, a
leading cause of blindness around the world. We believe we have
only begun to unlock the potential of targeting C3 across serious
retinal, rare, and neurological diseases. For more information,
please visit http://apellis.com or follow us
on Twitter and LinkedIn.
Investor Contact: Meredith
Kaya meredith.kaya@apellis.com617.599.8178
Apellis Pharmaceuticals (NASDAQ:APLS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Apellis Pharmaceuticals (NASDAQ:APLS)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024